cryptogamesthatmakemoney| Heplatinum Pharmaceuticals-B(02142.HK): Entering into a licensing and option agreement with AstraZeneca for a new tumor-targeted therapy

Glonghui May 23 丨 Heplatinum Pharmaceuticals-B(02142cryptogamesthatmakemoney.HK) issued an announcementcryptogamesthatmakemoney, Nona Biotech (Suzhou) Co., Ltd.("Nona Biotech"), a wholly-owned subsidiary of the company, has collaborated with AstraZeneca (LSE) to combine preclinical monoclonal antibodies used to create tumor-targeted therapies